• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用者付费对药品消费的影响。实证证据与经济影响。

The impact of user charges on the consumption of drugs. Empirical evidence and economic implications.

作者信息

Gerdtham U G, Johannesson M

机构信息

Centre for Health Economics, Stockholm School of Economics, Sweden.

出版信息

Pharmacoeconomics. 1996 Jun;9(6):478-83. doi: 10.2165/00019053-199609060-00002.

DOI:10.2165/00019053-199609060-00002
PMID:10160475
Abstract

Expenditure on drugs is increasing rapidly in many countries, and this has led to increased interest in measures to contain drug expenditure. One measure that has been discussed is to increase user charges for prescription drug. In this article, we consider whether or not raising user charges decreases the consumption of drugs. We also discuss how to judge if increased user charges for drugs are desirable from an economic viewpoint. We conclude that the decision to increase user charges for prescription drugs should not be viewed as an issue of cost containment, but as a matter of balancing the societal costs against the societal benefits of increased user charges.

摘要

在许多国家,药品支出正在迅速增加,这引发了人们对控制药品支出措施的更多关注。一种被讨论的措施是提高处方药的使用者付费。在本文中,我们探讨提高使用者付费是否会减少药品消费。我们还讨论了如何从经济角度判断提高药品使用者付费是否可取。我们得出结论,提高处方药使用者付费的决定不应被视为成本控制问题,而应看作是在权衡提高使用者付费的社会成本与社会效益之间的平衡问题。

相似文献

1
The impact of user charges on the consumption of drugs. Empirical evidence and economic implications.使用者付费对药品消费的影响。实证证据与经济影响。
Pharmacoeconomics. 1996 Jun;9(6):478-83. doi: 10.2165/00019053-199609060-00002.
2
Effects of user charges on the use of prescription medicines in different socio-economic groups.使用者付费对不同社会经济群体处方药使用情况的影响。
Health Policy. 1998 May;44(2):123-34. doi: 10.1016/s0168-8510(98)00009-8.
3
Relationship between increasing prescription charges and consumption in groups not exempt from charges.非免费用药群体中处方费用增加与用药量之间的关系。
J R Coll Gen Pract. 1986 Apr;36(285):154-6.
4
Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure.患者费用与国民保健制度处方药的使用:一些采用协整程序的估计
Health Econ. 1995 May-Jun;4(3):213-20. doi: 10.1002/hec.4730040306.
5
Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.老年人处方药成本的通胀与成本控制:来自不列颠哥伦比亚省的证据
Health Policy. 2004 Jun;68(3):299-307. doi: 10.1016/j.healthpol.2003.10.006.
6
Spending on medicines in Israel in an international context.以色列药品支出的国际背景。
Isr Med Assoc J. 2005 May;7(5):286-91.
7
Hidden costs: the direct and indirect impact of user fees on access to malaria treatment and primary care in Mali.隐性成本:在马里,用户付费对疟疾治疗和初级保健的可及性的直接和间接影响。
Soc Sci Med. 2012 Nov;75(10):1786-92. doi: 10.1016/j.socscimed.2012.07.015. Epub 2012 Aug 1.
8
Influence of simple computerized feedback on prescription charges in an ambulatory clinic. A randomized clinical trial.
Med Care. 1986 Jun;24(6):472-81. doi: 10.1097/00005650-198606000-00002.
9
Charging for health care: evidence on the utilisation of NHS prescribed drugs.医疗保健收费:关于国民保健制度处方药使用情况的证据
Soc Sci Med. 1991;33(6):681-7. doi: 10.1016/0277-9536(91)90022-5.
10
Prescription charges and the evaluation of health policies.处方费用与卫生政策评估。
Med J Aust. 1991 Mar 4;154(5):303-4. doi: 10.5694/j.1326-5377.1991.tb112877.x.

引用本文的文献

1
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?是时候重新审视欧洲药品患者自付费用的作用了吗?
Eur J Health Econ. 2012 Feb;13(1):1-5. doi: 10.1007/s10198-011-0353-8.
2
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.处方药费用对效率和公平有何影响?来自高收入国家的证据。
Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.

本文引用的文献

1
The effect of patient charges on the utilisation of prescription medicines.
J Health Econ. 1989 Mar;8(1):109-32. doi: 10.1016/0167-6296(89)90011-8.
2
Health insurance and the demand for medical care: evidence from a randomized experiment.健康保险与医疗需求:来自一项随机试验的证据。
Am Econ Rev. 1987 Jun;77(3):251-77.
3
Willingness to pay for antihypertensive therapy--further results.支付抗高血压治疗费用的意愿——进一步结果
J Health Econ. 1993 Apr;12(1):95-108. doi: 10.1016/0167-6296(93)90042-d.
4
Willingness to pay for antihypertensive therapy--results of a Swedish pilot study.支付抗高血压治疗费用的意愿——一项瑞典试点研究的结果
J Health Econ. 1991;10(4):461-73. doi: 10.1016/0167-6296(91)90025-i.
5
Some interim results from a controlled trial of cost sharing in health insurance.一项医疗保险费用分担对照试验的一些中期结果。
N Engl J Med. 1981 Dec 17;305(25):1501-7. doi: 10.1056/NEJM198112173052504.
6
Termination from Medi-Cal--does it affect health?医疗补助终止——这会影响健康吗?
N Engl J Med. 1984 Aug 16;311(7):480-4. doi: 10.1056/nejm198408163110735.
7
Does free care improve adults' health? Results from a randomized controlled trial.免费医疗能改善成年人的健康状况吗?一项随机对照试验的结果。
N Engl J Med. 1983 Dec 8;309(23):1426-34. doi: 10.1056/NEJM198312083092305.
8
The demand for prescription drugs as a function of cost-sharing.作为成本分摊函数的处方药需求。
Soc Sci Med. 1985;21(10):1063-9. doi: 10.1016/0277-9536(85)90161-3.
9
Does more generous dental insurance coverage improve oral health?更慷慨的牙科保险覆盖范围会改善口腔健康吗?
J Am Dent Assoc. 1985 May;110(5):701-7. doi: 10.14219/jada.archive.1985.0407.
10
Relationship between increasing prescription charges and consumption in groups not exempt from charges.非免费用药群体中处方费用增加与用药量之间的关系。
J R Coll Gen Pract. 1986 Apr;36(285):154-6.